基本药物“零差价”管制政策效果评估

发布时间：2018-01-21 09:20

  本文关键词： 基本药物 零差价 药价虚高 医改　出处：《探索》2017年02期 　论文类型：期刊论文

【摘要】：药品价格虚高是当前我国医改需直面的主要问题。基本药物"零差价"管制政策试图通过政府招标价、医院采购价和药品零售价三价合一的方式,来切断医药之间的利益链条,达到终结"以药养医"的政策目标。基于目标测评法,对基本药物"零差价"进行政策效果评估的结论为:药价虚高主要由于行政性公立医院垄断所致,"零差价"管制政策并不能完全有效消除"以药养医"体制,并会伴随一些管制内生性问题。政策实施会使医院的议价能力降低,医生拿回扣等商业贿赂行为向基层医院扩展,医院或医生合法赚取的"显性租金"演变成暗箱操作的"隐形租金"。这就导致政策目标出现了医院亏损面扩大和药费不降反升的偏差。建议尊重市场规律,发挥医院和医生主体作用,合理利用医保支付方式来控制费用。
[Abstract]:The virtual high of drug price is the main problem that needs to be faced directly in the medical reform of our country at present. The "zero difference" control policy of essential drugs tries to combine the government bidding price, the hospital purchase price and the drug retail price. To cut off the chain of interests between medicine, to achieve the end of the "medical care with medicine" policy objectives. Based on the objective evaluation method. The conclusion of the policy evaluation on the "zero difference" of essential drugs is that the deficiency of drug price is mainly caused by the monopoly of administrative public hospitals, and the "zero difference" control policy can not completely eliminate the system of "raising medicine with drugs". The implementation of the policy will reduce the bargaining power of the hospital, doctors will take kickbacks and other commercial bribery to expand to the grass-roots hospitals. The "explicit rent" legally earned by a hospital or doctor has evolved into a "hidden rent" operating in a dark box. This has led to a deviation in the policy objective of expanding the loss side of the hospital and increasing the drug cost instead of falling. It is suggested that the market rule be respected. Give play to the main role of hospitals and doctors, reasonable use of medical insurance payment to control costs.
【作者单位】： 湖南师范大学马克思主义学院;
【分类号】：R95
【正文快照】： 1引言药品价格虚高是当前我国医改需要直面的主要问题,也是国际学术界的热点问题。许多国家通过对药品价格调控或管制来控制医疗费用的增长[1],但是学者们基本上反对直接干预药品价格[2]。为解决患者“看病贵”问题,国内学术界主要存在两种观点:一种观点认为药价虚高的根源在，

本文编号：1451090